Samuel D Abbou

6PUBLICATIONS
147CO-AUTHORS
Central nervous systemMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 03, 2024
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions.

Audrey-Anne Lamoureux, Michael J Fisher, Lauriane Lemelle

|May 24, 2024
Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving ALK-Targeted Therapy.

Charles Bobin, Yasmine Iddir, Charlotte Butterworth

|Dec 05, 2023
Phase I/II Study of the WEE1 Inhibitor Adavosertib (AZD1775) in Combination with Carboplatin in Children with Advanced Malignancies: Arm C of the AcSé-ESMART Trial.

Susanne A Gatz, Anne C Harttrampf, Caroline Brard

|Mar 29, 2022
Rapid and highly sensitive approach for multiplexed somatic fusion detection.

Samuel Abbou, Sarah Finstuen-Magro, Brigit McDannell

|Jan 08, 2019
Assessment of circulating tumor DNA in pediatric solid tumors: The promise of liquid biopsies.

Samuel D Abbou, David S Shulman, Steven G DuBois

Pageof 1